1. Home
  2. SELX vs APRE Comparison

SELX vs APRE Comparison

Compare SELX & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

BUY

Current Price

$0.35

Market Cap

11.3M

Sector

N/A

ML Signal

BUY

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
APRE
Founded
2021
2006
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
11.5M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
SELX
APRE
Price
$0.35
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.10
AVG Volume (30 Days)
4.8M
180.8K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.22
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.55
52 Week High
$1.48
$2.22

Technical Indicators

Market Signals
Indicator
SELX
APRE
Relative Strength Index (RSI) 52.65 38.23
Support Level $0.34 $0.57
Resistance Level $0.46 $1.00
Average True Range (ATR) 0.07 0.08
MACD 0.02 -0.02
Stochastic Oscillator 36.18 10.31

Price Performance

Historical Comparison
SELX
APRE

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

Share on Social Networks: